Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aadi Bioscience, Inc. - Common Stock (NQ:AADI)

2.050 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aadi Bioscience, Inc. - Common Stock

< Previous 1 2 Next >
Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?
Aadi Bioscience secures ADC portfolio license, involving $44 million upfront and $805 million in milestones plus royalties. 
Via Benzinga
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
This American Express Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Cancer Focused-Aadi Bioscience Stock Plunges As Solid Tumor Trial Falls Short Of Expectations
Aadi Bioscience halts its PRECISION1 trial of nab-sirolimus in solid tumors with TSC1/TSC2 mutations due to insufficient efficacy. The company will focus on maximizing Fyarro sales, pausing new... 
Via Benzinga
Aadi Bioscience Earnings Preview
Via Benzinga
Preview: Aadi Bioscience's Earnings
Via Benzinga
Earnings Preview: Aadi Bioscience
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
3 Russell 2000 Stocks to Sell in July Before They Crash & Burn
These are three Russell 2000 stocks to sell before they damage your hard-earned investment portfolio in the long run. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
AADI Stock Earnings: Aadi Bioscience Misses EPS, Misses Revenue for Q1 2024
AADI stock results show that Aadi Bioscience missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are... 
Via Benzinga
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Cancer Player Aadi Bioscience Downgraded: Analyst Highlights 'Worse Than Expected' Response Rates
Friday, Aadi Bioscience Inc (NASDAQ: AADI) released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in... 
Via Benzinga
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Edges Higher; Darden Restaurants Earnings Top Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 60 points on Friday. The Dow traded up 0.11% to 37,288.04 while the NASDAQ rose 0.45% to 14,827.63. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
FSLR Stock Alert: First Solar Scores New ‘Buy’ Rating
First Solar stock is rising on Friday as investors in FSLR react to a new "buy" rating and $211 price target from Jefferies. 
Via InvestorPlace
US Stocks Mixed; Costco Posts Upbeat Earnings
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 75 points on Friday. The Dow traded down 0.20% to 37,173.96 while the NASDAQ rose 0.31% to 14,806.71. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Mangoceuticals (MGRX) Stock Down 33% Today?
Mangoceuticals stock is falling on Friday after the company put into effect a public offering for shares of MGRX. 
Via InvestorPlace
Why Is Anti-Cancer Focused Aadi Bioscience Stock Trading Lower Today?
Aadi Bioscience Inc (NASDAQ: AADI) shares are trading lower after the company released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic... 
Via Benzinga
Why Is Aadi Bioscience (AADI) Stock Down 56% Today?
Aadi Bioscience stock is taking a beating on Friday as investors in AADI react negatively to interim data from a clinical trial. 
Via InvestorPlace
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 46 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.